BibTex format
@inproceedings{Patel:2016:10.1038/bmt.2016.48,
author = {Patel, A and Jhanji, S and Pavlu, J and Laffan, M and Ethell, M and Bradshaw, A and Olavarria, E and Harrington, K and Apperley, J and Brett, S},
doi = {10.1038/bmt.2016.48},
pages = {S129--S129},
publisher = {Nature Publishing Group},
title = {Mesenchymal stromal stem cell (MSC) immunotherapy for experimental septic shock: systematic review and meta-analysis with trial sequential analysis of mortality},
url = {http://dx.doi.org/10.1038/bmt.2016.48},
year = {2016}
}
RIS format (EndNote, RefMan)
TY - CPAPER
AU - Patel,A
AU - Jhanji,S
AU - Pavlu,J
AU - Laffan,M
AU - Ethell,M
AU - Bradshaw,A
AU - Olavarria,E
AU - Harrington,K
AU - Apperley,J
AU - Brett,S
DO - 10.1038/bmt.2016.48
EP - 129
PB - Nature Publishing Group
PY - 2016///
SN - 1476-5365
SP - 129
TI - Mesenchymal stromal stem cell (MSC) immunotherapy for experimental septic shock: systematic review and meta-analysis with trial sequential analysis of mortality
UR - http://dx.doi.org/10.1038/bmt.2016.48
UR - http://hdl.handle.net/10044/1/32839
ER -
Critical care involves the care of the sickest patients in the hospital. Critically ill patients have usually been through a significant insult to their body (such as trauma, infection, burn) and have developed organ failure and require life-support. Critical Care is the largest theme bringing together clinicians and scientists from diverse backgrounds and includes collaborative research from hospitals throughout north-west London. Investigations range from evaluating biological mechanisms of organ failure through to the development of innovative technologies which allow the short-term and long-term support and recovery of organs.